Kisaco Onco Cell Therapy Summit, June 29-30, 2022 (Boston)
How to Deliver Safe and Effective Adoptive Cell Therapy Products to Clinical Promise, Commercial Scale Manufacturing and Patients
About Ayal Ronen
This author has not written his bio yet.
But we are proud to say that Ayal Ronen contributed 564 entries already.
Entries by Ayal Ronen
Immuno-Oncology Innovation Forum, May 24-25, 2022 (online)
The event brings together leaders from cancer research institutes, patient advocacy groups, early and late-stage investors, pharmas, & biotechs. 300+, 20+ company presentations, 50+% attendees are corporate and financial investors, analysts, bankers and advisors.
Digital RESI, June 7-9, 2022 (online)
Your opportunity to connect with investors and strategic partners, Digital RESI June focuses on early-stage funding for all life science verticals: drugs, devices, diagnostics, digital health.
LSX World Congress USA, June 21-22, 2022 (Boston)
LSX is an community of senior life science & healthcare decision-makers that develops connections with the capital and partners we need to grow our businesses.
Webinar: $7+ Billion in Cancer Research Funding Opportunities 2022
NCI and CDMRP are awarding over $7 BILLION in funding for cancer R&D. To learn more, listen to our free webinar about these opportunities.
Cancer Research in 2022: More than $7 Billion in Funding Opportunities
Find out about more than $7 Billion In Funding Opportunities for Cancer Research – and our webinar all about them
$130 Million in Funding Opportunities from PRCRP
The Peer Reviewed Cancer Research Program (PRCRP) of the Congressionally Directed Medical Research Programs (CDMRP) has just announced $130 million in funding opportunities for fiscal year 2022.
PRCRP Priorities for Fiscal Year 2022
In fiscal year 2022 the Peer Reviewed Cancer Research Program (PRCRP) of the Congressionally Directed Medical Research Programs (CDMRP) will provide funds for research into cancers…
CDMRP Funding Opportunities 2022
CDMRP announced research funding opportunities for fiscal year 2022. CDMRP aim to fund high-risk, high-gain, high-impact projects which other funding agencies may overlook and thus to fill research gaps in critical areas. The FreeMind Group hosted a webinar about these new opportunities. Get the recording, slides, and critical forms here.
ALS Research Funding Opportunities from CDMRP in 2022
The Congressionally Directed Medical Research Programs (CDMRP) have announced their research funding opportunities for fiscal year 2022. Here’s an overview of the ALS funding opportunities. Learn more about these awards and others in our upcoming webinar, Wednesday, March 30, 2022, 1 PM (Eastern).
Website Links
Address
FreeMind Group
6 Liberty Square #2783
Boston, MA 02109